.jpg?format=webp&width=780)
The advent of a new generation of targeted cancer drugs requires a radically different design of early clinical trials. Here, the authors discuss why new clinical trial designs are needed and what is being done. Such innovative trials can lead to similar outcomes for cancer patients with fewer side effects, while at the same time reducing the cost of cancer care.
Like
Save
Share